Here we investigated the ability of Acetyl-L-carnitine (ALCAR) to interfere with key functional properties of prostate cancer progression and angiogenesis in vitro and in vivo and identified target molecules modulated by ALCAR
This corporate interference, according to the pharma, is prohibited under California law
Early clinical observations and small studies hint at reduced alcohol intake among patients taking GLP-1R agonists, although large, controlled trials are still limited
Pathophysiology, diagnosis, treatment, and genetics of carpal tunnel syndrome: a review
characteristics and goal achievement of patients with type 2 diabetes mellitus treated with basal insulin and physician-perceived barriers to achieving glycemic targets
These improper listings can delay generic drug competition as a result of triggering automatic litigation stays, increase litigation costs that could disincentivize the development of generic drugs, and increase costs across the healthcare system